These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24496338)

  • 1. Dyslipidemia as a risk factor for primary intracerebral hemorrhage.
    Lučić Prokin A; Čuzdi A; Zivanović Z; Sekarić J; Kokai Zekić T; Popović N; Novaković Paro J
    Med Glas (Zenica); 2014 Feb; 11(1):31-6. PubMed ID: 24496338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epidemiological survey of lipid levels and factors in Kazakan people over 30-year old in Fukang of Xinjiang].
    Liang DP; Yao XG; Li NF; Zhang DL; Guo YY; Lin L; Zhou L; Li WC; Yan ZT; Wang HM; Luo WL; Chang JH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 May; 45(5):440-3. PubMed ID: 21756789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic loci for serum lipid fractions and intracerebral hemorrhage.
    Akoudad S; Ikram MA; Portegies ML; Adams HH; Bos D; Hofman A; Koudstaal PJ; Uitterlinden AG; van der Lugt A; van Duijn CM; Vernooij MW
    Atherosclerosis; 2016 Mar; 246():287-92. PubMed ID: 26820804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolemia as one of the risk factors of intracerebral hemorrhage.
    Bozluolcay M; Nalbantoglu M; Gozubatik-Celik RG; Benbir G; Akalin MA; Erkol G
    Acta Neurol Belg; 2013 Dec; 113(4):459-62. PubMed ID: 23801430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study.
    Wieberdink RG; Poels MM; Vernooij MW; Koudstaal PJ; Hofman A; van der Lugt A; Breteler MM; Ikram MA
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2982-9. PubMed ID: 21921260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database.
    Sazonov V; Beetsch J; Phatak H; Wentworth C; Evans M
    Atherosclerosis; 2010 Jan; 208(1):210-6. PubMed ID: 19766999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol efflux and metabolic abnormalities associated with low high-density-lipoprotein-cholesterol and high triglycerides in statin-treated coronary men with low-density lipoprotein-cholesterol <70 mg/dl.
    Posadas-Sánchez R; Posadas-Romero C; Mendoza-Pérez E; Caracas-Portilla NA; Cardoso-Saldaña G; Medina-Urrutia A; Jorge-Galarza E; Juárez-Rojas JG
    Am J Cardiol; 2012 Mar; 109(5):636-41. PubMed ID: 22169129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of eight genetic variants as novel determinants of dyslipidemia in Japanese by exome-wide association studies.
    Yamada Y; Sakuma J; Takeuchi I; Yasukochi Y; Kato K; Oguri M; Fujimaki T; Horibe H; Muramatsu M; Sawabe M; Fujiwara Y; Taniguchi Y; Obuchi S; Kawai H; Shinkai S; Mori S; Arai T; Tanaka M
    Oncotarget; 2017 Jun; 8(24):38950-38961. PubMed ID: 28473662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma lipid level and incidence of dyslipidemia in workers of Chongqing enterprises and institutions].
    Gao Y; Zhong XN; Yang YH; Tian KC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):432-5. PubMed ID: 22883098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serum lipid levels on stroke outcome after rt-PA therapy: SAMURAI rt-PA registry.
    Makihara N; Okada Y; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Hasegawa Y; Kario K; Okuda S; Naganuma M; Toyoda K
    Cerebrovasc Dis; 2012; 33(3):240-7. PubMed ID: 22261711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
    Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
    J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of subjects with very low serum low-density lipoprotein cholesterol and the risk for intracerebral hemorrhage.
    Lee JG; Koh SJ; Yoo SY; Yu JR; Lee SA; Koh G; Lee D
    Korean J Intern Med; 2012 Sep; 27(3):317-26. PubMed ID: 23019397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
    Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of Attainment of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Goals in Cardiovascular Clinical Practice (from the National Cardiovascular Data Registry PINNACLE Registry).
    Spinler SA; Cziraky MJ; Willey VJ; Tang F; Maddox TM; Thomas T; Dueñas GG; Virani SS;
    Am J Cardiol; 2015 Aug; 116(4):547-53. PubMed ID: 26089010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of dyslipidemia in moderate to severe meibomian gland dysfunction.
    Dao AH; Spindle JD; Harp BA; Jacob A; Chuang AZ; Yee RW
    Am J Ophthalmol; 2010 Sep; 150(3):371-375.e1. PubMed ID: 20619393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of high-density lipoprotein cholesterol levels in elderly diabetic individuals with type IIb dyslipidemia: A 2-year survey of cardiovascular events.
    Ina K; Hayashi T; Araki A; Kawashima S; Sone H; Watanabe H; Ohrui T; Yokote K; Takemoto M; Kubota K; Noda M; Noto H; Ding QF; Zhang J; Yu ZY; Yoon BK; Nomura H; Kuzuya M;
    Geriatr Gerontol Int; 2014 Oct; 14(4):806-10. PubMed ID: 24215618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.